Ambrx Biopharma is a California-based biologics company that uses advanced technology to discover and develop engineered precision biologics, including its lead product candidate ARX788, a drug being tested for various cancer treatment trials. In addition to ARX788, the company has two other earlier-stage product candidates and is developing several product candidates aiming to target immuno-oncology applications, in preclinical and clinical trials. Ambrx Biopharma collaborates with renowned names in the pharmaceutical industry like Bristol Myers Squibb Company; AbbVie Inc.; BeiGene; Sino Biopharmaceutical Co., Ltd.; NovoCodex; and Elanco Animal Health.